The UK has approved Foundayo, the first oral weight-loss treatment in Europe, providing a potential alternative for those avoiding injectable therapies, pending NHS funding approval. The UK has become the first country in Europe to approve a new oral weight-loss…
Apollo Spectra Hospital in Alwarpet introduces an advanced super specialty clinic for diabetic foot care, aiming to improve early detection and reduce amputations as India’s diabetes epidemic accelerates. Apollo Spectra Hospital in Alwarpet, Chennai, has opened an Advanced Super Specialty…
Researchers at UC San Diego have developed CHARM, a smart ring capable of analysing sweat for metabolic biomarkers, potentially revolutionising real-time health monitoring and diabetes management. Researchers at the University of California, San Diego have developed a smart ring that…
A new prototype smart ring, CHARM, can monitor glucose, ketones, and other biomarkers in real time by analysing sweat, potentially transforming health management for conditions like diabetes. Researchers at the University of California San Diego have unveiled a prototype smart…
Meitheal Pharmaceuticals has gained FDA approval for GARZULYS, a rapid-acting insulin biosimilar, intensifying competition in a market historically dominated by originator products and few biosimilar entries. Meitheal Pharmaceuticals said on July 30, 2026 that the U.S. Food and Drug Administration…
The UK has authorised Eli Lilly’s Foundayo, a once-daily oral GLP-1 medication for weight management and type 2 diabetes, marking a significant development in accessible obesity treatments across Europe. The UK has become the first country in Europe to clear…
Eli Lilly’s shares rose nearly 4% after the UK’s MHRA approved Foundayo, its first weight-loss pill, marking a key milestone in the competitive obesity treatment market and granting the company a European foothold. Eli Lilly’s shares climbed nearly 4% on…
Egypt’s Health Ministry has responded to criticism over insulin imports, emphasising local manufacturing capabilities and distinguishing between brand shortages and overall drug availability to reassure diabetic patients amid ongoing debates on medicine imports. Egypt’s Health Ministry has moved to calm…
A Cleveland Clinic-led analysis uncovers ongoing challenges in tailoring diabetes treatment for seniors, showing many are not receiving appropriate adjustments based on blood-sugar levels and overall health status. A Cleveland Clinic-led analysis suggests many older adults with type 2 diabetes…
A study involving nearly 90,000 patients uncovers discrepancies between treatment changes and individualised glycaemic targets in older adults, raising concerns over overtreatment and undertreatment in diabetes management. Among older adults with type 2 diabetes, treatment changes often do not match…
